The primary research applications include: Researchers at academic institutions, pharmaceutical companies, and independent laboratories worldwide use GHK-Cu for in-vitro studies, cell culture experiments, and animal model research
Ongoing Clinical Trials Numerous questions remain under investigation, including: Long-term biological effects Extended safety profiles Pharmacodynamic characteristics Receptor-level adaptations Combination therapy applications As a result, ongoing clinical trials continue to generate new information regarding the compounds biological activity and potential future applications
MIC (Methionine, Inositol, Choline) helps with fat metabolism, assisting in weight loss and fat breakdown
Additionally, these compounds stimulate -oxidation of fatty acids, promote lipolysis, and suppress lipogenesis, collectively improving lipid metabolism and reducing fat accumulation (498)
Long non-coding RNA Xist regulates oocyte loss via suppressing miR-23b-3p/miR-29a-3p maturation and upregulating STX17 in perinatal mouse ovaries